Clinical Trials
New research from Turkey, Canada and the United Kingdom in the area of clinical trials detailed
Published in Heart Disease Weekly, September 17th, 2006
Study 1: Glycoprotein IIb/IIIa inhibition after successful percutaneous coronary intervention (PCI) prevented minor myocardial necrosis and provided longer-lasting recovery in QT dispersion compared to heparin therapy.
A recent report from Turkey notes, "Coronary ischemia augments inhomogeneity in ventricular repolarization. Decrease in the QT dispersion (QTd) following restoration of coronary blood flow to the ischemic myocardium by successful percutaneous coronary intervention (PCI) is an expected outcome."
E. Okmen and colleagues at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2006-09-17)
More Articles from Heart Disease Weekly
- Cardiology
Canine mitral regurgitation model shows rotigaptide reduces atrial fibrillation vulnerability - Cardiology
IKr contributes to altered ventricular repolarization that determines long-term cardiac memory - Cardiovascular Disease
Functional tricuspid regurgitation is characterized by larger, more planar, and circular annulus - Heart Failure
Acute heart failure was diagnosed in patients with obstructive airway disease using NT-proBNP - Heart Failure
Survival of heart failure patients is similar for those with/without preserved ejection fraction - Angiology
Amplatzer vascular plug can facilitate coil occlusion of parent vessels - More from this issue of Heart Disease Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
